Submissions from 2015
Anneau vaginal à la progesterone: Appel a l'action pour combler les ecarts importants dans la planification familiale postnatal, Population Council
Anneau vaginal à progestérone: aussi sûr pour maman que pour bébé, Population Council
Anneau vaginal à progestérone: évite les grossesses, Population Council
Delivering contraceptive vaginal rings, Population Council
Distribution d'anneaux vaginaux contraceptifs, Population Council
Expanding access to long-acting reversible contraceptives, Population Council
Progesterone vaginal ring: A call-to-action to fill critical gaps in post-partum family planning, Population Council
Progesterone vaginal ring: Beneficial role in birth spacing, Population Council
Progesterone vaginal ring: Prevents pregnancy, Population Council
Progesterone vaginal ring: Safe for mothers and babies, Population Council
Strengthening the role of patent medicine vendors in the provision of injectable contraception in Nigeria, Population Council and The Evidence Project
Progesterone vaginal ring: Results of a three-country acceptability study, Saumya RamaRao, Heather Clark, Deepa Rajamani, Salisu Mohammed Ishaku, Babacar Mane, Francis Obare, Harriet Birungi, Nafissatou Diop, Wilson Liambila, Fatou Mbow, Chi-Chi Undie, Godwin Unumeri, and John Townsend
Enhancing contraceptive choice for postpartum women in sub-Saharan Africa with the progesterone vaginal ring: A review of the evidence, Saumya RamaRao, Salisu Mohammed Ishaku, Wilson Liambila, and Babacar Mane
Applying emerging science to contraception research: Implications for the clinic, Régine Sitruk-Ware and Anita Nath
A novel intravaginal ring to prevent HIV-1, HSV-2, HPV, and unintended pregnancy, Shweta Ugaonkar, Asa Wesenberg, Jolanta Wilk, Samantha Seidor, Olga Mizenina, Larisa Kizima, Aixa Rodriguez, Shimin Zhang, Keith Levendosky, Jessica Kenney, Meropi Aravantinou, Nina Derby, Brooke Grasperge, Agegnehu Gettie, James F. Blanchard, Narender Kumar, Kevin Roberts, Melissa Robbiani, José Fernández-Romero, and Thomas Zydowsky
Delivering contraceptive vaginal rings: Review of postpartum and postnatal care programs in Nigeria, Godwin Unumeri and Salisu Mohammed Ishaku
Delivering contraceptive vaginal rings—Task sharing policies and practices in the delivery of family planning services: Experiences from Nigeria, Godwin Unumeri and Salisu Mohammed Ishaku
Submissions from 2014
Increasing choice of and access to family planning services via outreach in Rajasthan, India, Kumudha Aruldas, M.E. Khan, Jaleel Ahmad, and Anvita Dixit
A randomized study on pharmacodynamic effects of vaginal rings delivering the progesterone receptor modulator ulipristal acetate: Research for a novel estrogen-free, method of contraception, Yong-mei Huang, Jeffrey T. Jensen, Vivian Brache, Leila Cochen, Alistair Williams, Marie-José Miranda, Horacio B. Croxatto, Narender Kumar, Heather Sussman, Elena Hoskin, Marlena Gehret Plagianos, Kevin Roberts, Ruth Merkatz, Diana Blithe, and Régine Sitruk-Ware
Medical barriers to emergency contraception: A cross-sectional survey of doctors in North India, M.E. Khan, Anvita Dixit, Isha Bhatnagar, and Martha Brady
Acceptability of the Nestorone®/ethinyl estradiol contraceptive vaginal ring: Development of a model; implications for introduction, Ruth Merkatz, Marlena Gehret Plagianos, Michael Cooney, Elena Hoskin, Paul C. Hewett, and Barbara Mensch
Assessing the potential market for a progesterone contraceptive vaginal ring (PCVR) as a new contraceptive option in sub-Saharan Africa using needs-based market segmentation, Francis Obare, Deepa Rajamani, and Saumya RamaRao
Increasing access to family planning in Ghana through policy change: Task-sharing to enable auxiliary nurses to provide contraceptive implant services, Population Council
Acceptability of a transdermal gel-based male hormonal contraceptive in a randomized controlled trial, Mara Y. Roth, Grace Shih, Niloufar Ilani, Christina Wang, Stephanie T. Page, William J. Bremner, Ronald S. Swerdloff, Régine Sitruk-Ware, Diana Blithe, and John K. Amory
Patent: Multi-layered gradient vaginal ring, Bruce Variano, Jeffrey Speck, Teresa Sallent, and Simone Evans
Submissions from 2013
Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism, Johannes Bitzer, Jean-Jacques Amy, Rob Beerthuizen, Martin Birkhauser, Teresa Bombas, Mitchell Creinin, Philip Darney, Lisa Ferreira Vicente, Kristina Gemzell-Danielsson, Bruno Imthurn, Jeffrey T. Jensen, Andrew M. Kaunitz, Ali Kubba, Medard M. Lech, Diana Mansour, Gabriele Merki, Thomas Rabe, Katrina Sedlecki, David Serfaty, Jacques Seydoux, Lee P. Shulman, Régine Sitruk-Ware, Sven O. Skouby, Anne Szarewski, James Trussell, and Carolyn Westhoff
Why do we need male contraceptives?, C. Yan Cheng and Dolores D. Mruk
Patent: Unique combinations of antimicrobial compositions, Robin A. Maguire, Mitchell Thorn, David M. Phillips, and Naomi Rutenberg
A greenprint for sustainable contraceptive research and development, Kirsten Moore, John Townsend, Jeff Spieler, Patricia S. Coffey, Diana Blithe, Elizabeth Arndorfer, and Elizabeth Dawes
7a-methyl-19-nortestosterone (MENT®): The Population Council's contribution to research on male contraception and treatment of hypogonadism, Eberhard Nieschlag, Narender Kumar, and Régine Sitruk-Ware
Safety and adherence of a non-medicated intravaginal ring (IVR) (MTN-005), Population Council
Progesterone vaginal ring: Introducing a contraceptive to meet the needs of breastfeeding women, Saumya RamaRao, Heather Clark, Ruth Merkatz, Heather Sussman, and Régine Sitruk-Ware
New vision for contraceptive research and development, Régine Sitruk-Ware and Peter J. Donaldson
Progesterone and related progestins: Potential new health benefits, Régine Sitruk-Ware and Martine El-Etr
Characteristics and metabolic effects of estrogen and progestins contained in oral contraceptive pills, Régine Sitruk-Ware and Anita Nath
Contraception technology: Past, present and future, Régine Sitruk-Ware; Anita Nath; and Daniel R. Mishell, Jr.
Submissions from 2012
Patent: Methods and compositions for emergency contraception using endothelin receptor antagonists, Indrani C. Bagchi and Régine Sitruk-Ware
Effects of a novel estrogen-free, progesterone receptor modulator-contraceptive vaginal ring on inhibition of ovulation, bleeding patterns and endometrium in normal women, Vivian Brache; Régine Sitruk-Ware; A. Williams; Diana Blithe; Horacio B. Croxatto; Narender Kumar; Sushma Kumar; Yun-yen Tsong; Irving Sivin; Anita Nath; Heather Sussman; Leila Cochon; Marie-José Miranda; Veronica Reyes; Anibal Faundes; and Daniel R. Mishell, Jr.
A new combination of testosterone and nestorone transdermal gels for male hormonal contraception, Niloufar Ilani, Mara Y. Roth, John K. Amory, Ronald S. Swerdloff, Clint Dart, Stephanie T. Page, William J. Bremner, Régine Sitruk-Ware, Narender Kumar, Diana Blithe, and Christina Wang
Country mapping: Nigeria, Salisu Mohammed Ishaku and Saumya RamaRao
Country mapping: Senegal, Babacar Mane, Nafissatou Diop, Nancy Termini LaChance, Saumya RamaRao, and Heather Clark
Country mapping: Kenya, Francis Obare, Wilson Liambila, Harriet Birungi, Eseoise Itombra, Heather Clark, and Saumya RamaRao
Bellagio consensus: Recommendations for action to increase access to highly effective, long-acting, reversible contraception, Population Council
Le consensus de Bellagio : Recommandations pour améliorer l'accès aux méthodes de contraception efficaces, réversibles à longue durée d'action, Population Council
Nonclinical development needs and regulatory requirements for multipurpose prevention technologies: A primer, Joseph W. Romano, Martha Brady, and Judy Manning
Submissions from 2011
Constructing a critical path for product development, commercialization, and access, Martha Brady
Facilitating regulatory approval of multipurpose prevention technologies for sexual and reproductive health, Martha Brady
What regulatory guidance exists for multipurpose prevention technologies (MPTs)? A review of key guidance documents and their applicability to MPTs, Martha Brady and Heeyoung Park
Male contraception: Where do we go from here?, C. Yan Cheng and Dolores D. Mruk
Nomegestrol acetate, a novel progestogen for oral contraception, Alfred O. Mueck and Régine Sitruk-Ware
Condom use before marriage and its correlates: Evidence from India, K.G. Santhya, Rajib Acharya, and Shireen J. Jejeebhoy
Metabolic effects of contraceptive steroids, Régine Sitruk-Ware and Anita Nath
New strategies for providing hormonal contraception in developing countries, John Townsend, Régine Sitruk-Ware, Katherine Williams, Ian Askew, and Klaus Brill
Evaluation of the impact of the voucher and accreditation approach on improving reproductive health behaviors and status in Kenya, Charlotte E. Warren, Timothy Abuya, Francis Obare Onyango, Joseph Sunday, Rebecca Njue, Ian Askew, and Benjamin Bellows
Submissions from 2010
Emergency contraception: Idea to program, Saumya RamaRao, John Townsend, and Sarah Raifman
Submissions from 2009
Premarital sexual behaviour among unmarried college students of Gujarat, India, Rachna Sujay
Nurse auxiliaries as providers of intrauterine devices for contraception in Guatemala and Honduras, Ricardo Vernon
Submissions from 2008
Delivering non-hormonal contraceptives to men: Advances and obstacles, Dolores D. Mruk and C. Yan Cheng
New contraceptive developments, Population Council
Increasing women's use of the IUD for family planning, Ricardo Vernon
Submissions from 2007
An initial pharmacokinetic study with a Metered Dose Transdermal System® for delivery of the progestogen Nestorone® as a possible future contraceptive, Ian S. Fraser, Edith Weisberg, Narender Kumar, Sushma Kumar, Andrew J. Humberstone, Louise McCrossin, Deborah Shaw, Yun-yen Tsong, and Régine Sitruk-Ware
The changing position of IUDs in reproductive health services in developing countries: Opportunities and challenges, John Townsend and Roy Jacobstein
Submissions from 2005
Delivery options for contraceptives, Régine Sitruk-Ware
Submissions from 2004
Patent: Androgen as a male contraceptive and non-contraceptive androgen replacement, Alfred J. Moo-Young
Submissions from 2002
The female condom: Dynamics of use in urban Zimbabwe, Horizons Program
Jadelle® levonorgestrel rod implants: A summary of scientific data and lessons learned from programmatic experience, Irving Sivin, Harold A. Nash, and Sandra N. Waldman
Submissions from 2000
Rights, technology, and services in reproductive health: A report from a meeting, Marion Carter and C. Elizabeth McGrory
Patent: Silicone core long term androgen delivery implant, Alfred J. Moo-Young and Saleh I. Saleh
Submissions from 1999
Patent: Progesterone vaginal ring for treatment of infertility, Theodore M. Jackanicz, Horacio B. Croxatto, Leopoldo Glasser Drexler, and Fernando Zegers-Hochschild
Patent: Intravaginal rings with insertable drug-containing core, Saleh I. Saleh, Harold A. Nash, C. Wayne Bardin, and Troy Harmon
Comparing alternative products in the provision of emergency contraception, John P. Skibiak, Yusuf Ahmed, and M. Ketata
Testing strategies to improve access to emergency contraception pills: Prescription vs. prophylactic distribution, John P. Skibiak, Yusuf Ahmed, and M. Ketata
Submissions from 1998
Covert contraceptive use: Prevalence, motivations, and consequences, Ann E. Biddlecom and Bolaji M. Fapohunda
Patent: Method of preparation of ester derivatives of steroids, Fang Li
Patent: Male contraceptive implant, Alfred J. Moo-Young and Saleh I. Saleh
Peru logistics chain analysis, Jeanne Noble and James R. Foreit
Management support for postabortion operations research at the Egyptian Fertility Care Society, Population Council
Submissions from 1997
Patent: Subdermally implantable device, Alfred J. Moo-Young
Patent: Therapeutically effective topical application of ST1435, Alfred J. Moo-Young, Ana Zepeda-Ortega, and Horacio B. Croxatto
DMPA provision in PSS clinics in Uttar Pradesh: Costs and prices, Saumya RamaRao, John Townsend, Leila Caleb-Varkey, Sudha Tiwari, Sneh Vishwanath, and Harbans Singh
Submissions from 1994
Patent: Leydig cell stimulator, C. Yan Cheng and C. Wayne Bardin
Patent: [Gln']-luteinizing Hormone Releasing Hormone Conjugate of Tetanus Vaccine and its uses, Anna E. Ladd, Rosemarie B. Thau, and Yun-yen Tsong
Profile of clients of different providers of family planning services in Egypt, Social Planning, Analysis & Administration Consultants (SPAAC)
Submissions from 1993
Employment-based family planning services, Placide Tapsoba, Ian Askew, J. Tunde Taylor Thomas, Sering Falu Njie, and Momodou Jasseh
Submissions from 1992
The Copper T 380 Intrauterine Device: A Summary of Scientific Data, Irving Sivin, Forrest Greenslade, Frederick H. Schmidt, and Sandra N. Waldman
Submissions from 1986
Patent: Medicated Intracervical and Intrauterine Devices, Tapani Luukkainen and Ahti M.K. Liukkonen
Submissions from 1982
Patent: Method for making an IUD with shrinking of a medicated attachment onto a support, Dale N. Robertson and John Braun
Submissions from 1981
Patent: Manufacture of long term contraceptive implant, Gopi N. Gupta
Patent: Intravaginal ring, Harold A. Nash and Daniel R. Mishell Jr.
Submissions from 1973
Patent: Filament winding apparatus, Howard J. Tatum, Nils A. Jernberg, and John Braun